AORT · Artivion, Inc.
$29.14
+0.73 (+2.57%)
At close · Aug 14
Market Cap
$1.42B
Shares
48.76M
Artivion, Inc. Earnings Call Transcripts
Every quarterly earnings call for Artivion, Inc. (AORT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲6.4%
$76.84M
−$13.71M
'22 Q3
22-11-03
▲0%
$79.40M
$2.17M
'22 Q4
23-02-16
▲7.8%
$83.23M
−$13.53M
'23 Q1
23-05-04
▲11.1%
$89.25M
−$3.38M
'23 Q2
23-08-03
▲14.3%
$87.85M
−$9.80M
'23 Q3
23-11-02
▲18%
$93.67M
−$3.98M
'23 Q4
24-02-15
▲17.1%
$97.43M
$7.53M
'24 Q1
24-05-06
▲9.8%
$98.02M
−$2.12M
'24 Q2
24-08-08
▲9%
$95.78M
−$2.29M
'24 Q3
24-11-07
▲3.9%
$97.31M
−$16.48M
'24 Q4
25-02-24
▲1.6%
$98.98M
−$505,000
'25 Q1
25-05-05
▲15.3%
$112.97M
$1.34M
'25 Q2
25-08-07
▲18.4%
$113.39M
$6.50M
'25 Q3
25-11-06
▲19.2%
$115.99M
$2.43M
'25 Q4
26-02-12
▲17.5%
$116.34M
$1.42M
'26 Q1
26-05-07
LATEST
▲11.3%
$125.76M
−$13.51M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Artivion, Inc. Q2 FY2026 Earnings Call
Revenue
$125.76M
▲ 11.3% YoY Diluted EPS
$-0.28
▼ 1033.3% YoY Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
2026 Truist Securities MedTech Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Artivion, Inc. Q1 FY2026 Earnings Call
Positive tone
AMDS commercialization
Endospan/Nexus acquisition
Pipeline and clinical trials
Revenue
$116.34M
▲ 17.5% YoY Diluted EPS
$0.03
Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
Artivion, Inc. Q4 FY2025 Earnings Call
Confident tone
Stent Grafts / AMDS
On-X Mechanical Valve
NEXUS / EndoSpan Partnership
Revenue
$115.99M*
▲ 19.2% YoY Gross margin
63.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Artivion, Inc. Q3 FY2025 Earnings Call
Confident tone
AMDS Stent Graft Growth and U.S. Launch
Pipeline and Future Launches (NEXUS, Arcevo, CVO)
On-X Mechanical Valve Momentum
Revenue
$113.39M
▲ 18.4% YoY Diluted EPS
$0.13
Gross margin
65.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Artivion, Inc. Q2 FY2025 Earnings Call
Confident tone
AMDS U.S. launch following HDE approval
On-X mechanical heart valve growth
Stent graft portfolio and pipeline expansion
Revenue
$112.97M
▲ 15.3% YoY Diluted EPS
$0.03
Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Artivion, Inc. Q1 FY2025 Earnings Call
Confident tone
AMDS U.S. launch
Cybersecurity recovery and tissue backlog
On-X mechanical valve growth
Revenue
$98.98M
▲ 1.6% YoY Diluted EPS
$-0.01
▼ 105.6% YoY Gross margin
64.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-24
Artivion, Inc. Q4 FY2024 Earnings Call
Confident tone
AMDS HDE approval and launch
Stent graft portfolio
Capital structure and Endospan option
Revenue
$97.31M*
▲ 3.9% YoY Gross margin
63.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Artivion, Inc. Q3 FY2024 Earnings Call
Confident tone
Product portfolio results
Revenue growth and financial performance
AMDS regulatory progress
Revenue
$95.78M
▲ 9% YoY Diluted EPS
$-0.05
Gross margin
63.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Artivion, Inc. Q2 FY2024 Earnings Call
Confident tone
Leverage and margin expansion outlook
Endospan/NEXUS partnership update
Stent graft portfolio performance
Revenue
$98.02M
▲ 9.8% YoY Diluted EPS
$-0.05
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Artivion, Inc. Q1 FY2024 Earnings Call
Confident tone
On-X Aortic Valve
International Expansion
AMDS / PERSEVERE Trial
Revenue
$97.43M
▲ 17.1% YoY Diluted EPS
$0.18
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
Artivion, Inc. Q4 FY2023 Earnings Call
Confident tone
Clinical trial results
Product revenue growth
Profitability and cash flow
Revenue
$93.67M*
▲ 18% YoY Gross margin
65.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Artivion, Inc. Q3 FY2023 Earnings Call
Revenue
$87.85M
▲ 14.3% YoY Diluted EPS
$-0.24
Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Artivion, Inc. Q2 FY2023 Earnings Call
Revenue
$89.25M
▲ 11.1% YoY Diluted EPS
$-0.08
Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Artivion, Inc. Q1 FY2023 Earnings Call
Revenue
$83.23M
▲ 7.8% YoY Diluted EPS
$-0.33
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
Artivion, Inc. Q4 FY2022 Earnings Call
Revenue
$79.40M*
▲ 0% YoY Gross margin
64.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Artivion, Inc. Q3 FY2022 Earnings Call
Revenue
$76.84M
▲ 6.4% YoY Diluted EPS
$-0.34
▼ 230.8% YoY Gross margin
63.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Artivion, Inc. Q2 FY2022 Earnings Call
Revenue
$80.34M
▲ 5.5% YoY Diluted EPS
$-0.11
Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Artivion, Inc. Q1 FY2022 Earnings Call
Revenue
$77.21M
▲ 8.6% YoY Diluted EPS
$-0.08
Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Artivion, Inc. Q4 FY2021 Earnings Call
Revenue
$79.39M*
▲ 16.9% YoY Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Artivion, Inc. Q3 FY2021 Earnings Call
Revenue
$72.21M
▲ 10.9% YoY Diluted EPS
$0.26
Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Artivion, Inc. Q2 FY2021 Earnings Call
Revenue
$76.15M
▲ 41.6% YoY Diluted EPS
$-0.06
Gross margin
66.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Artivion, Inc. Q1 FY2021 Earnings Call
Revenue
$71.09M
▲ 7% YoY Diluted EPS
$-0.08
Gross margin
67.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Artivion, Inc. Q4 FY2020 Earnings Call
Revenue
$67.90M*
▼ 2.6% YoY Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Artivion, Inc. Q3 FY2020 Earnings Call
Revenue
$65.13M
▼ 4.1% YoY Diluted EPS
$-0.08
Gross margin
66.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-02
Artivion, Inc. Q2 FY2020 Earnings Call
Revenue
$53.77M
▼ 24.4% YoY Diluted EPS
$-0.10
▼ 242.9% YoY Gross margin
66.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-01
Artivion, Inc. Q1 FY2020 Earnings Call
Revenue
$66.43M
▼ 1.6% YoY Diluted EPS
$-0.18
Gross margin
66.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Artivion, Inc. Q4 FY2019 Earnings Call
Revenue
$69.70M
▲ 2.8% YoY Diluted EPS
$-0.02
Gross margin
66.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls
Key facts
CIK
784199
CUSIP
228903100
13F (30d)
196 filings
194 filers
Visit website
Investor relations